Nimotuzumab combined with chemotherapy as first‐line treatment for advanced lung squamous cell carcinoma

BACKGROUND: This study was conducted to evaluate the efficacy and safety of nimotuzumab combined with chemotherapy as first‐line therapy in advanced lung squamous cell carcinoma (LSCC), and to explore predictive biomarkers of the efficacy of nimotuzumab. METHODS: A retrospective study was conducted...

Descripción completa

Detalles Bibliográficos
Autores principales: Si, Xiaoyan, Wu, Shafei, Wang, Hanping, Zhang, Xiaotong, Wang, Mengzhao, Zeng, Xuan, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068447/
https://www.ncbi.nlm.nih.gov/pubmed/29920955
http://dx.doi.org/10.1111/1759-7714.12789

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068447/
https://www.ncbi.nlm.nih.gov/pubmed/29920955
http://dx.doi.org/10.1111/1759-7714.12789

Ejemplares similares